Acute Lung Injury Regulation by Hyaluronan.

Area of Science:

• Pulmonary medicine
• Biochemistry
• Cell biology

Background:

• Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are severe conditions with high mortality and limited treatments.
• Disruption of the pulmonary endothelial and epithelial barriers is a key pathological feature, leading to lung airspace leakage.
• Degradation of hyaluronan (HA) contributes to endothelial glycocalyx damage and loss of pulmonary vascular integrity in ALI/ARDS.

Purpose of the Study:

• To review the dichotomous role of hyaluronan (HA) in ALI/ARDS based on its molecular weight and associated binding proteins.
• To explore the potential therapeutic applications of high molecular weight HA in managing ALI/ARDS.

Main Methods:

• Literature review focusing on the role of hyaluronan in ALI/ARDS.
• Analysis of studies investigating the effects of different molecular weights of HA.
• Examination of the interaction between HA and HA-binding proteins in the context of lung injury.

Main Results:

• Hyaluronan (HA) exhibits a dual role, promoting ALI/ARDS in certain contexts and offering protection in others.
• Degradation of HA is linked to endothelial barrier dysfunction and increased vascular permeability.
• Exogenous administration of high molecular weight HA has demonstrated protective effects in experimental ALI models.

Conclusions:

• The effect of hyaluronan (HA) on acute lung injury (ALI) is dependent on its size and the presence of specific binding proteins.
• High molecular weight HA presents a promising therapeutic avenue for treating ALI and acute respiratory distress syndrome (ARDS).